Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.
Van Bockstal M, Baldewijns M, Colpaert C, Dano H, Floris G, Galant C, Lambein K, Peeters D, Van Renterghem S, Van Rompuy AS, Verbeke S, Verschuere S, Van Dorpe J. Van Bockstal M, et al. Among authors: lambein k. Histopathology. 2018 Dec;73(6):923-932. doi: 10.1111/his.13741. Epub 2018 Oct 22. Histopathology. 2018. PMID: 30168167
Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast.
Van Bockstal M, Lambein K, Smeets A, Slembrouck L, Neven P, Nevelsteen I, Weltens C, Van Limbergen E, Christiaens MR, Van Ongeval C, Wildiers H, Libbrecht L, Floris G. Van Bockstal M, et al. Among authors: lambein k. Eur J Surg Oncol. 2019 Apr;45(4):550-559. doi: 10.1016/j.ejso.2018.11.005. Epub 2018 Nov 12. Eur J Surg Oncol. 2019. PMID: 30454971
Immune-related adverse events after a single dose of pembrolizumab.
Vos H, Lambein K, Wildiers H, Punie K, Smeets A. Vos H, et al. Among authors: lambein k. Eur J Cancer. 2021 May;148:92-94. doi: 10.1016/j.ejca.2021.01.048. Epub 2021 Mar 16. Eur J Cancer. 2021. PMID: 33740501 Clinical Trial. No abstract available.
Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study.
Van Bockstal MR, François A, Altinay S, Arnould L, Balkenhol M, Broeckx G, Burguès O, Colpaert C, Dedeurwaerdere F, Dessauvagie B, Duwel V, Floris G, Fox S, Gerosa C, Hastir D, Jaffer S, Kurpershoek E, Lacroix-Triki M, Laka A, Lambein K, MacGrogan GM, Marchiò C, Martin Martinez MD, Nofech-Mozes S, Peeters D, Ravarino A, Reisenbichler E, Resetkova E, Sanati S, Schelfhout AM, Schelfhout V, Shaaban A, Sinke R, Stanciu-Pop CM, van Deurzen CHM, Van de Vijver KK, Van Rompuy AS, Vincent-Salomon A, Wen HY, Wong S, Bouzin C, Galant C. Van Bockstal MR, et al. Among authors: lambein k. Mod Pathol. 2021 Dec;34(12):2130-2140. doi: 10.1038/s41379-021-00865-z. Epub 2021 Jul 3. Mod Pathol. 2021. PMID: 34218258 Free PMC article.
49 results